USPTO serial 79211856
KISTOSYN
Reviewed by CopyMark Law Group
Reg. 5597954Status 709
- Filing date
- Status date
- Registration date
- Nov 6, 2018
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KISTOSYN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Aldehydes for pharmaceutical purposes; alginate dietary supplements; aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; anti-oxidant food supplements; antioxidant enriched coffee for medical purposes; antibiotics; antibiotics for human use; mineral food supplements; food supplements in the nature of anti-oxidants in pill form; mineral waters for medical purposes; asthmatic tea; bacteriological preparations for medical and veterinary use; cultures of microorganisms and biological tissue cultures all for medical and veterinary use; bacterial poisons; bacterial preparations for medical and veterinary use; medicinal diaper rash ointments; medicinal ointments for treating dermatological conditions; balms for medical purposes; gurjun balsam preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases for both medical and veterinary purposes; medicated skin care lotions; skin care creams for medical use; wheat germ dietary supplements; melissa water for pharmaceutical purposes; gallic acid for pharmaceutical purposes; stick liquorice for pharmaceutical purposes; medicinal herbs in the nature of fennel; dietary fiber to aid digestion; dietary fiber for treating constipation; yeast for pharmaceutical purposes; yeast dietary supplements; yeast extracts for pharmaceutical purposes; pharmaceutical preparations, namely, elixirs for the treatment of viral and bacterial infections; enzymes for medical purposes; enzyme preparations for medical purposes; cardiotonics; enzyme dietary supplements; expectorants composed of eucalyptol; eucalyptus for pharmaceutical purposes; sterilising preparations; disinfectants; disinfectants and antiseptics; germicides; disinfectants other than disinfectant soap; disinfectants for medical instruments; fumigants; glucose for medical purposes; dietetic by-products of the processing of cereals adapted for medical purposes; glucose dietary supplements; glucose preparations for medical purposes; fungicides; fungicides for medical use; biological fungicides; fungal extracts sold as a component ingredient of nutritional supplements and vitamins; medicinal tea; medicinal drinks; medicinal herbs; medicated candy; extracts of medicinal herbs; herbal teas for medicinal purposes; nutritionally fortified herbal beverages for medical purposes; medicinal herbal extracts for medical purposes; pharmaceutical preparations for the treatment of respiratory diseases; medicated lozenges; sugar-coated medicated lozenges; medicated food supplements; herbal extracts for medical purposes; plant extracts for medical purposes; herbal pills for the treatment of diabetes; natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; medicinal herbal preparations; rhubarb roots for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; medicinal herbs for smoking cessation; herbal teas for medicinal purposes; urinary tract disinfectants; anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue featuring irish moss; iodine; iodine for pharmaceutical purposes; potassium, sodium and silver iodides for pharmaceutical purposes; camphor oil for medical purposes; camphor for medical purposes; candy for medical purposes; dill oil for medical purposes; capsules sold empty for pharmaceuticals; parasiticides; disposable wipes impregnated with pharmaceutical lotions; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use on plastic and metal surface objects; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in households, vehicles, hotels and hospitals; pre-moistened medicated wipes; ointments for pharmaceutical purposes; sulfur sticks as disinfectants; flowers of sulfur for pharmaceutical purposes; angostura bark for medical purposes; mangrove bark for pharmaceutical purposes; quebracho bark for medical use; condurango bark for medical purposes; croton bark for medical purposes; collodion for pharmaceutical purposes; extracts of hops for pharmaceutical purposes; air purifying preparations; disinfectant washes for sanitary purposes; sanitary sterilizing preparations in the nature of washes; royal jelly for pharmaceutical purposes; royal jelly dietary supplements; mint for pharmaceutical purposes; menthol for pharmaceutical purposes; mentholated ointment for medical use; mustard poultices for pharmaceutical purposes; medicated body powder composed of mustard; mustard oil for medical purposes; medicinal herb preparations composed of mustard; medicinal roots; myrobalan barks for pharmaceutical purposes; prescription and non-prescription medicines, namely, capsules and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal oils; medicated lozenges for the treatment of respiratory diseases; cough lozenges for medical use; pollen dietary supplements; propolis for pharmaceutical purposes; propolis dietary supplements; chewing gum for medical purposes; medicated bath salts; medicated mouthwash; mouthwashes for medical purposes; gargles for medical purposes; medicated anti-cavity mouth spray; medicated dental rinse; antiseptic mouthwashes; medicated mouthwashes, namely, antimicrobial mouthwashes; medicated serums for the treatment of the mouth and throat; syrups for pharmaceutical purposes for the treatment of the mouth for disinfection and for the treatment of respiratory diseases; tinctures of iodine for medical purposes; detergents for medical purposes; vaccines; vitamin tablets; vitamin preparations; vitamin supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; mixed vitamin preparations; gelatin capsules sold empty for pharmaceuticals; fumigation preparations for medical purposes; gurjun balsam for medical purposes; bronchodilating preparations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ceres Pharma Hungary Kft.
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks owned by Vitaplus Élelmiszer, Gyógyszergyártó és Kereskedelmi Korlátolt Felelosségu Társaság
- Other trademarks in Class 005
- Similar marks named KISTOSYN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 3, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 3, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 23, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 23, 2025 | C71T | CANCELLED SECTION 71 | — |
| Feb 8, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 10, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 9, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 6, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 17, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 1, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 1, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 1, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2018 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 14, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 14, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 9, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 12, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 26, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 26, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2017 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 20, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 20, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 12, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |